Trial Profile
Phase I trial of a biogenic amine reuptake inhibitor under development for CNS disorders
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Sep 2022
Price :
$35
*
At a glance
- Drugs Biogenic amine receptor antagonists (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 30 May 2011 Company MR states that phase II development is underway. Assumed that this trial has now been completed.
- 25 May 2011 Status changed from recruiting to completed, according to information in an AMRI media release.
- 11 Jun 2009 New trial record.